NCT03218007View on ClinicalTrials.gov

A2 AR as a Novel Biomarkers for Physician Decision-making Improvement Evaluation's Patients With Suspected Acute Coronary Syndrome But Negative Troponin.

NACompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

November 10, 2017

Primary Completion Date

May 15, 2019

Study Completion Date

May 15, 2019

Conditions
Acute Coronary Syndrome
Interventions
BIOLOGICAL

blood samples

to evaluate expression and functionnaly activity of A2AR

Trial Locations (1)

13354

Assistance Publique Hopitaux de Marseille, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT03218007 - A2 AR as a Novel Biomarkers for Physician Decision-making Improvement Evaluation's Patients With Suspected Acute Coronary Syndrome But Negative Troponin. | Biotech Hunter | Biotech Hunter